Clinical Cardiology

View the latest content related to this topic

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

The enhanced benefits seen for those with higher BMIs is in sync with growing interest in obesity-related HF.

L.A. McKeown

December 13, 2024

Slides

See all

Presentation AHA 2024

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Presenter: Steven E. Nissen

November 18, 2024

Presentation AHA 2024

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

Presenter: Marcely Gimenes Bonatto

November 18, 2024

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation TCT 2024

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

Presenter: Ryo Hikida

October 29, 2024

News

See all

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

By L.A. McKeown

December 13, 2024

News Daily News

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

By Yael L. Maxwell

December 13, 2024

News Daily News

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

By Caitlin E. Cox

December 12, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

By L.A. McKeown

December 12, 2024

News Daily News

Female-Specific Factors Don’t Enhance Common Risk Calculators

By Caitlin E. Cox

December 10, 2024

NY Valves 2024

June 5

June 07, 2024

EuroPCR 2024

May 14

May 17, 2024

ACC 2024

April 6

April 08, 2024

Videos on This Topic

See all

Advertisement

Clinical Cardiology

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Slides

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Female-Specific Factors Don’t Enhance Common Risk Calculators

More on This Topic

Conference Coverage

NY Valves 2024

EuroPCR 2024

ACC 2024

Videos on This Topic

Advertisement

Clinical Cardiology

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content